Navigation Links
New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women

CLEVELAND--(BUSINESS WIRE)--May 10, 2007 - An evaluation of the safety and effectiveness of local vaginal estrogen therapy for the treatment of vaginal atrophy, a frequent complaint of postmenopausal women, has just been released by The North American Menopause Society (NAMS). Entitled "The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society," the document was developed by an Editorial Board of five clinicians and researchers expert in this area of women's health, then approved by the NAMS Board of Trustees.

"Although hot flashes typically accompany the loss of ovarian estrogen production at menopause, they usually abate over time regardless of whether estrogen therapy is used," said Gloria A. Bachmann, MD, Associate Dean for Women's Health, Professor of Obstetrics and Gynecology and Professor of Medicine, UMDNJ, Robert Wood Johnson Medical School, New Brunswick, NJ, and Chair of the Editorial Board. "In contrast, vaginal symptoms (eg, vaginal dryness, vulvovaginal irritation and itching, and painful intercourse) are usually progressive and unlikely to resolve spontaneously. Left untreated, vaginal atrophy can result in years of discomfort, with a significant impact on quality of life. An estimated 10% to 40% of postmenopausal women have symptoms related to vaginal atrophy, yet only about 25% of symptomatic women seek medical help."

The new position statement represents the most authoritative state-of-the-science summary. Significant findings include:

-- Estrogen therapy, used either locally (ie, vaginally) or systemically (eg, orally, through the skin), is considered the therapeutic standard for moderate to severe vaginal atrophy.

-- Local vaginal delivery of estrogen is available in North America in government-approved therapies via cream, tablet, and ring--with fewer systemic effects than
'"/>




Page: 1 2 3

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Obama Statement on Bush Veto of Stem Cell Bill
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
5. Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
6. Northfield Laboratories Investor Update
7. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
8. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
9. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
10. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
11. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
Post Your Comments:
(Date:11/28/2008)...IS, Nov. 28 Eli Lilly an...mental New Drug Application (sNDA) from,the U.S. ... (duloxetine HCl),for the management of chronic p...he first half of 2009, adding data from a recently...is pain of the knee. , The decision does no...
(Date:11/25/2008)...areness can improve recovery , , Audio and ...ailable on the Mayo Clinic News Blog. Please see t..., ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewsw...roke patients don,t think they,re having a stroke ...l their condition worsens. The findings appear in ...
(Date:11/25/2008)... Calif., Nov. 25 Pharmac...at the company has completed a Phase 1,clinical t...-class,small-molecule Factor VIIa inhibitor. The ...teers to evaluate the safety and pharmacologic eff...27483 resulted in a linear dose,response in the I...
(Date:11/24/2008)..., N.J., Nov. 24 Leaders ...y provided an update for investors on the company,...ative portfolio that includes 46 new entities in c...n preclinical studies. , , "Research and de...ng-Plough as we continue our transformation," said...
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Tasker Products Receives USDA Authorization to Begin Commercialization of its Post Chill Spray Application 22581 1Tasker Products Receives USDA Authorization to Begin Commercialization of its Post Chill Spray Application 22581 2Tasker Products Receives USDA Authorization to Begin Commercialization of its Post Chill Spray Application 22581 3Joint nanotechnology forum to focus on electronics photonics renewable energy 6168 1Joint nanotechnology forum to focus on electronics photonics renewable energy 6168 2University of Pennsylvania engineers reveal what makes diamonds slippery at the nanoscale 6166 1University of Pennsylvania engineers reveal what makes diamonds slippery at the nanoscale 6166 2Tethered molecules act as light driven reversible nanoswitches 6164 1Tethered molecules act as light driven reversible nanoswitches 6164 2
... SPIRIT FIRST follow-up analysis shows no stent th... BARCELONA, Spain, May 22, 2007,/PRNewswire-FirstC...ed the results of additional data from the SPIRIT ...or safety and efficacy data,for the market-leading... Stent System and XIENCE(TM) V (PROMUS(TM)) Everol...
... Absorbable Stent Continues to Show Promise as Fut...2, 2007 /PRNewswire-FirstCall/ -- Abbott,today ann...irst,clinical trial evaluating the safety and perf...t platform for the treatment of,coronary artery di...ts in the trial, presented today at the EuroPCR me...
Other Medicine Technology:SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus,Drug-Eluting Coronary Stent Systems 2SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus,Drug-Eluting Coronary Stent Systems 3Abbott Announces Positive Nine-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2Abbott Announces Positive Nine-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3
(Date:12/2/2008)... Orion Health announces that the SouthEast Alaska ...ska, has selected the Rhapsody™ Integration ...ord, radiology, pharmacy, laboratory and business ...s to extend connectivity to statewide systems such...stry) and AKAIMS (an MIS and clinical documentatio...
(Date:12/1/2008)... 2 Including a patient,...e meticulous reading from the radiologist interpre...pathetic approach, according to a study presented ...ciety of North America (RSNA). , , "Our st...being and not as an anonymous case study," said le...
(Date:12/1/2008)...as found that the availability of a portable eight...gency room can significantly increase the number o...ving treatment. Results of the study, conducted at...in Salem, Mass., will be presented today at the an...America (RSNA). , "The hospital,s acquisition o...
(Date:12/1/2008)...Award, Engages with President on U.S. HIV/AIDS Ini...ring Saddleback Civil Forum on Global Health , ... George W. Bush was honored on the 20th anniversar... Medal of PEACE" given by Dr. Rick Warren on behal...ack Civil Forum on Global Health. The award, give...
Breaking Medicine News(10 mins):Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 2Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 3Health News:Portable CT increases chance of stroke survival and recovery 2Health News:President George W. Bush Receives 'International Medal of PEACE' That Coincides With PEPFAR Milestone on World Aids Day: 2Health News:President George W. Bush Receives 'International Medal of PEACE' That Coincides With PEPFAR Milestone on World Aids Day: 3Health News:President George W. Bush Receives 'International Medal of PEACE' That Coincides With PEPFAR Milestone on World Aids Day: 4Health News:President George W. Bush Receives 'International Medal of PEACE' That Coincides With PEPFAR Milestone on World Aids Day: 5
...and a few dollars more. This might seem sickening,...ling sick and dying and if that happens, //they hi...her. This trading or betting on someone’s life is ... must-have in today’s world. Life insurance is und...
...eventh of July is celebrated the world over as the...by the United Nations Population Fund in 1988, to ...the 5 billion mark. // The aim of the day is to...ulation and the importance of resolving these issu...
...y it brings, pregnancy is also a harbinger of unwa...nths without being bothered by this condition, but...feeling//. However it need not be a debilitating i...ke care of nausea. One of the main vitamins consid...
...n important role in the development of cancer. Pro...e in the cancer development//. It is found that ...wth. In the book titled The China Study which is p...by Dr. T. Colin Campbell a detailed analysis of th...
Other Medicine News:Health News:'Young and their Reproductive Health' - Theme of World Population Day 2Health News:Too Much Of Animal Protein May Lead To Cancer 2
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTT/1P chairs are reco
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Medicine Products: